title: Autoimmunity and intraperitoneal insulin treatment by programmable pumps: lack of relationship.
authors.forename: V
authors.initials: V
authors.lastname: Lassmann-Vague
authors.forename: M
authors.initials: M
authors.lastname: SanMarco
authors.forename: P J
authors.initials: PJ
authors.lastname: LeJeune
authors.forename: C
authors.initials: C
authors.lastname: Alessis
authors.forename: P
authors.initials: P
authors.lastname: Vague
authors.forename: P
authors.initials: P
authors.lastname: Belicar
mesh_terms: D000328:Adult; D001323:Autoantibodies / Q000032:analysis*; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000276:immunology*; D005260:Female; D006801:Humans; D015918:Infusion Pumps, Implantable; D007328:Insulin / Q000008:administration & dosage / Q000276:immunology* / Q000627:therapeutic use; D007332:Insulin Infusion Systems / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged
chemical_list: D001323:Autoantibodies; D007328:Insulin